Picture India in the 1930s. The country cannot manufacture its own medicines. Every tablet, every vial, every dose of quinine comes from abroad, priced however foreign companies see fit, available

India’s energy story is changing fast, and Adani Green Energy Limited (AGEL) sits right at the centre of it. As the country leans harder into clean power and pulls away

OpenAI has introduced a new sticker-making feature in ChatGPT, allowing users to create personalised sticker packs from photographs, written prompts and everyday ideas. The new ChatGPT Stickers tool can turn

In 1948, a father in a Rajasthani village carried his ten-year-old son on his shoulders for three hours because there was no hospital nearby, and no money for one closer.

Two brothers built one of India’s biggest hospital chains, then very nearly lost it to a boardroom war fought across three countries. That is the short version of the Fortis

A shuttered factory building in a Bengal town, empty for two years after its previous owner went bankrupt, became the unlikely starting point for one of India’s most recognised brands.

Eight million advertisers now run at least one AI-built ad creative on Meta’s platforms, roughly double the number a year earlier, per Meta’s own Q1 2026 earnings filing. That jump

Samsung will hold its next Galaxy launch event on August 27, with the company expected to introduce the Samsung Galaxy S26 FE as the latest addition to its flagship smartphone

Naveen Tewari finished his MBA at Harvard Business School in 2007. He had elite placement offers waiting. Instead, he flew back to Bangalore, pooled savings with three friends, and ran

Tesla shares climbed to their highest level in four weeks as investors responded to fresh signs that the electric vehicle maker is preparing to bring its Cybercab onto public roads

Combustion engines are not what they once used to be. The list of top 10 electric vehicle companies isn’t just full of carmakers anymore,  now you’ve got some maps running

Anthropic says its Claude artificial intelligence models have successfully designed new protein binders against 14 of 15 tested targets, marking a significant expansion of generative AI into early-stage drug research.